vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and INNOSPEC INC. (IOSP). Click either name above to swap in a different company.

INNOSPEC INC. is the larger business by last-quarter revenue ($455.6M vs $312.7M, roughly 1.5× Enact Holdings, Inc.). On growth, Enact Holdings, Inc. posted the faster year-over-year revenue change (3.6% vs -2.4%). Over the past eight quarters, Enact Holdings, Inc.'s revenue compounded faster (3.6% CAGR vs -4.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Innospec Inc., formerly known as Octel Corporation and Associated Octel Company, Ltd., is an American specialty chemical company. It comprises three business units:The Performance Chemicals business trades in the personal care, home care, agrochemical, mining and industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives. The Oilfield Services business supplies drilling, completion and production chemicals.

ACT vs IOSP — Head-to-Head

Bigger by revenue
IOSP
IOSP
1.5× larger
IOSP
$455.6M
$312.7M
ACT
Growing faster (revenue YoY)
ACT
ACT
+6.0% gap
ACT
3.6%
-2.4%
IOSP
Faster 2-yr revenue CAGR
ACT
ACT
Annualised
ACT
3.6%
-4.6%
IOSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACT
ACT
IOSP
IOSP
Revenue
$312.7M
$455.6M
Net Profit
$47.4M
Gross Margin
28.0%
Operating Margin
71.3%
10.3%
Net Margin
10.4%
Revenue YoY
3.6%
-2.4%
Net Profit YoY
167.3%
EPS (diluted)
$1.23
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
IOSP
IOSP
Q4 25
$312.7M
$455.6M
Q3 25
$311.5M
$441.9M
Q2 25
$304.9M
$439.7M
Q1 25
$306.8M
$440.8M
Q4 24
$301.8M
$466.8M
Q3 24
$309.6M
$443.4M
Q2 24
$298.8M
$435.0M
Q1 24
$291.6M
$500.2M
Net Profit
ACT
ACT
IOSP
IOSP
Q4 25
$47.4M
Q3 25
$12.9M
Q2 25
$23.5M
Q1 25
$32.8M
Q4 24
$-70.4M
Q3 24
$33.4M
Q2 24
$31.2M
Q1 24
$41.4M
Gross Margin
ACT
ACT
IOSP
IOSP
Q4 25
28.0%
Q3 25
26.4%
Q2 25
28.0%
Q1 25
28.4%
Q4 24
29.2%
Q3 24
28.0%
Q2 24
29.2%
Q1 24
31.1%
Operating Margin
ACT
ACT
IOSP
IOSP
Q4 25
71.3%
10.3%
Q3 25
67.4%
1.3%
Q2 25
70.4%
7.8%
Q1 25
68.9%
9.6%
Q4 24
68.9%
8.8%
Q3 24
74.1%
10.3%
Q2 24
78.6%
9.4%
Q1 24
70.6%
10.1%
Net Margin
ACT
ACT
IOSP
IOSP
Q4 25
10.4%
Q3 25
2.9%
Q2 25
5.3%
Q1 25
7.4%
Q4 24
-15.1%
Q3 24
7.5%
Q2 24
7.2%
Q1 24
8.3%
EPS (diluted)
ACT
ACT
IOSP
IOSP
Q4 25
$1.23
$1.90
Q3 25
$1.10
$0.52
Q2 25
$1.11
$0.94
Q1 25
$1.08
$1.31
Q4 24
$1.05
$-2.80
Q3 24
$1.15
$1.33
Q2 24
$1.16
$1.24
Q1 24
$1.01
$1.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
IOSP
IOSP
Cash + ST InvestmentsLiquidity on hand
$582.5M
$292.5M
Total DebtLower is stronger
$744.5M
Stockholders' EquityBook value
$5.4B
$1.3B
Total Assets
$6.9B
$1.8B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
IOSP
IOSP
Q4 25
$582.5M
$292.5M
Q3 25
$545.6M
$270.8M
Q2 25
$616.0M
$266.6M
Q1 25
$639.0M
$299.8M
Q4 24
$602.8M
$289.2M
Q3 24
$674.9M
$303.8M
Q2 24
$711.3M
$240.2M
Q1 24
$624.3M
$270.1M
Total Debt
ACT
ACT
IOSP
IOSP
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
Q1 24
$746.1M
Stockholders' Equity
ACT
ACT
IOSP
IOSP
Q4 25
$5.4B
$1.3B
Q3 25
$5.3B
$1.3B
Q2 25
$5.2B
$1.3B
Q1 25
$5.1B
$1.3B
Q4 24
$5.0B
$1.2B
Q3 24
$5.0B
$1.2B
Q2 24
$4.8B
$1.2B
Q1 24
$4.7B
$1.2B
Total Assets
ACT
ACT
IOSP
IOSP
Q4 25
$6.9B
$1.8B
Q3 25
$6.9B
$1.8B
Q2 25
$6.8B
$1.8B
Q1 25
$6.7B
$1.8B
Q4 24
$6.5B
$1.7B
Q3 24
$6.6B
$1.8B
Q2 24
$6.3B
$1.7B
Q1 24
$6.3B
$1.7B
Debt / Equity
ACT
ACT
IOSP
IOSP
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
IOSP
IOSP
Operating Cash FlowLast quarter
$724.5M
$61.4M
Free Cash FlowOCF − Capex
$46.8M
FCF MarginFCF / Revenue
10.3%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$88.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
IOSP
IOSP
Q4 25
$724.5M
$61.4M
Q3 25
$192.0M
$39.3M
Q2 25
$119.5M
$9.3M
Q1 25
$226.7M
$28.3M
Q4 24
$686.3M
$25.7M
Q3 24
$188.1M
$73.5M
Q2 24
$144.7M
$4.7M
Q1 24
$187.3M
$80.6M
Free Cash Flow
ACT
ACT
IOSP
IOSP
Q4 25
$46.8M
Q3 25
$25.0M
Q2 25
$-3.7M
Q1 25
$19.9M
Q4 24
$13.6M
Q3 24
$65.8M
Q2 24
$-6.2M
Q1 24
$69.9M
FCF Margin
ACT
ACT
IOSP
IOSP
Q4 25
10.3%
Q3 25
5.7%
Q2 25
-0.8%
Q1 25
4.5%
Q4 24
2.9%
Q3 24
14.8%
Q2 24
-1.4%
Q1 24
14.0%
Capex Intensity
ACT
ACT
IOSP
IOSP
Q4 25
3.2%
Q3 25
3.2%
Q2 25
3.0%
Q1 25
1.9%
Q4 24
2.6%
Q3 24
1.7%
Q2 24
2.5%
Q1 24
2.1%
Cash Conversion
ACT
ACT
IOSP
IOSP
Q4 25
1.30×
Q3 25
3.05×
Q2 25
0.40×
Q1 25
0.86×
Q4 24
Q3 24
2.20×
Q2 24
0.15×
Q1 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACT
ACT

Segment breakdown not available.

IOSP
IOSP

Refinery And Performance$147.0M32%
Personal Care$99.7M22%
Oilfield Services$93.1M20%
Other Fuel Specialties$47.1M10%
Other Performance Chemicals$40.0M9%
Home Care$28.7M6%

Related Comparisons